Trial intelligence / Profile preview

Adding Metformin to Insulin for Pregestational and Gestational Diabetes

NCT03106870Completed

Sponsor
Ain Shams University
Start
Jun 2016
Primary completion
Dec 2016
Modality
Small Molecules
01

Overview

Randomised, open-label trial of liquid metformin (Aspargo Labs) in gestational diabetes mellitus (GDM) and pregestational diabetes mellitus (PDM) (2 arms), sponsored by Ain Shams University. Primary endpoint: Number of Participants With Glycemic Control. Started Jun 2016; status: completed.

02

Drugs

liquid metformin (Aspargo Labs)
03

Conditions

gestational diabetes mellitus (GDM)pregestational diabetes mellitus (PDM)

Beyond the preview

Go deeper on NCT03106870.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03106870.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call